These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14128977)

  • 1. [INVESTIGATIONS ON THE PROBLEM OF THE DETECTION OF LIVE INFLUENZA VACCINES. I. RESULTS OF A TEST OF LIVE A2-INFLUENZA-VACCINES IN A CONTROLLED EXPERIMENT WITH VOLUNTEERS].
    STARKE G; SIEBELIST I; HILLER E
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():37-43. PubMed ID: 14128977
    [No Abstract]   [Full Text] [Related]  

  • 2. COMPARATIVE STUDY OF THE IMMUNOLOGICAL PROPERTIES OF LIVE INFLUENZA VACCINE IN VOLUNTEERS.
    RITOVA VV; ZHUKOVSKY AM; YEVSTIGNEYEVA NA
    J Hyg Epidemiol Microbiol Immunol; 1963; 7():272-80. PubMed ID: 14110339
    [No Abstract]   [Full Text] [Related]  

  • 3. [FIELD TRIALS OF LIVE ATTENUATED ASIAN INFLUENZA VIRUS VACCINE (OKUNO VACCINE)].
    GOTOE H
    Sapporo Igaku Zasshi; 1963 Sep; 24():211-5. PubMed ID: 14192251
    [No Abstract]   [Full Text] [Related]  

  • 4. [INFLUENCE OF THE NUMBER OF DOSES ON THE EPIDEMIOLOGICAL EFFICACY OF LIVE VACCINE AGAINST INFLUENZA].
    SMORODINTSEV AA; BUROV SA; DOKUCHAEV GM; MINCHEV PN; FILIPPOV NA; CHALKINA OM
    Vopr Virusol; 1963; 22():286-91. PubMed ID: 14075847
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sero-epidemiological investigations of the effectiveness of influenza vaccine with attenuated live viruses of types A2 and B].
    Ivan A; Vancea G; Zvorişteanu V; Oană C; Rusu F; Gherman A; Meleghi M
    Stud Cercet Inframicrobiol; 1968; 19(5):355-61. PubMed ID: 5716054
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions].
    Vavilova IuG; Gorev NE; Zykov MP
    Vopr Virusol; 1976; (2):158-61. PubMed ID: 820079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on live influenza virus vaccine. II. Evaluation of cold-adapted influenza A2 Hong Kong virus in volunteers (author's transl)].
    Mizutani H; Izuchi T
    Uirusu; 1973 Jun; 23(2):141-7. PubMed ID: 4808070
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study.
    Helmeke C; Gräfe L; Irmscher HM; Gottschalk C; Karagiannis I; Oppermann H
    PLoS One; 2015; 10(4):e0122910. PubMed ID: 25885063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to combined live influenza virus vaccines administered intranasally.
    Peetermans J; Lamy F; Delem A
    Dev Biol Stand; 1975; 28():340-6. PubMed ID: 1126578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of an interferonogen--oral live influenza vaccine A2B for treating influenza].
    Ostrovskiĭ NN; Vengerov II; Lazukina LN; Koiudenko LG; Alekseeva AK
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):54-6. PubMed ID: 4616545
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
    Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
    Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
    Rudenko L; Kiseleva I; Stukova M; Erofeeva M; Naykhin A; Donina S; Larionova N; Pisareva M; Krivitskaya V; Flores J;
    Vaccine; 2015 Sep; 33(39):5110-7. PubMed ID: 26296497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on live influenza virus vaccine. I. Attenuated influenza A2 Hong Kong virus and its biological and immunological characteristics (author's transl)].
    Izuchi T; Mizutani H
    Uirusu; 1973 Jun; 23(2):134-40. PubMed ID: 4808069
    [No Abstract]   [Full Text] [Related]  

  • 18. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
    Ennis FA; Yi-Hua Q; Schild GC
    J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.